Group 1 - The fifth extraordinary general meeting of shareholders was held on December 17, 2025, at the company's conference room in Haining, Zhejiang Province [2][3] - The meeting was presided over by the chairman, Zhu Yangang, and utilized a combination of on-site and online voting methods, complying with relevant laws and regulations [2][3] - All resolutions proposed at the meeting were passed with more than half of the valid voting rights held by attending shareholders [3][4] Group 2 - The first board meeting of the eleventh session was also held on December 17, 2025, with all nine directors present, including two participating via remote voting [7][8] - Zhu Yangang was elected as the chairman of the eleventh board of directors with unanimous support [8][9] - The board approved the election of Zhu Yangang as the representative of the company for executing company affairs, maintaining the same legal representative [11][12] Group 3 - The board elected two vice chairpersons, Shen Yanming and Mo Weny, with unanimous support [13][14] - The formation of various specialized committees of the board was approved, including the Strategy Committee, Nomination Committee, Audit Committee, and Compensation and Assessment Committee, with designated conveners [14][15][16][17] - The board appointed Zhu Yangang as the general manager and Lu Pingyan as the board secretary, both of whom have the necessary qualifications [18][19] Group 4 - The board also appointed four vice general managers and a financial director, all of whom have relevant experience and qualifications [19][20] - The term for all appointed personnel is three years, aligning with the term of the eleventh board of directors [20] - The company provided contact information for the board secretary and securities representative for further inquiries [20]
浙江钱江生物化学股份有限公司2025年第五次临时股东会决议公告